Pharmexcil has told Modi govt that Indian generics constitute 10% of the US generic market in value terms & the order may give Indian drugmakers a chance to capture more.
The drug is a combination of ‘decitabine and cedazuridine’, which are used as agents for chemotherapy. But it may not be affordable for a large section of Indian patients.
European Medicines Agency tells Hyderabad-based Hetero Labs to test its diabetes medicine pioglitazone for “low levels” of cancer-causing substance in them.
By pairing Indian drone engineering with Japanese semiconductor expertise, the two firms aim to develop more advanced autonomous systems tailored to both defence & commercial use.
American objectives are unmet. They neither have muscle nor motivation to resume the war. As for Iran, the regime didn’t just survive, it’s now led by more radical individuals.
COMMENTS